Our findings may go beyond tumor-induced immune dysfunction; defects in IFN signaling have been documented in other chronic diseases in which immune dysfunction has been described, e.g., chronic hepatitis C infection and multiple sclerosis [38,39]. This evidence concerns the gene IFNA1 and multiple sclerosis.